Home/Filings/4/0001376339-22-000114
4//SEC Filing

Stein Robert Benjamin 4

Accession 0001376339-22-000114

CIK 0001376339other

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 8:17 PM ET

Size

6.4 KB

Accession

0001376339-22-000114

Insider Transaction Report

Form 4
Period: 2022-09-12
Stein Robert Benjamin
EVP, Research and Development
Transactions
  • Sale

    Common Stock

    2022-09-12$3.44/sh19,000$65,284287,002 total
  • Sale

    Common Stock

    2022-09-13$3.46/sh8,329$28,785278,673 total
Footnotes (1)
  • [F1]The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $3.42 to $3.45, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Issuer

MIMEDX GROUP, INC.

CIK 0001376339

Entity typeother

Related Parties

1
  • filerCIK 0001597158

Filing Metadata

Form type
4
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 8:17 PM ET
Size
6.4 KB